Gene therapy for hemophilia represents a groundbreaking advancement in hemophilia treatment, offering new hope for patients like Terence Blue, who have long struggled with daily injections of clotting factors.This innovative approach harnesses the power of gene therapy innovations to potentially eliminate the need for conventional clotting factor therapy by correcting the underlying genetic defect responsible for hemophilia B.